These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 11038449
1. Ectodermal abnormalities associated with methimazole intrauterine exposure. Martin-Denavit T, Edery P, Plauchu H, Attia-Sobol J, Raudrant D, Aurand JM, Thomas L. Am J Med Genet; 2000 Oct 02; 94(4):338-40. PubMed ID: 11038449 [No Abstract] [Full Text] [Related]
2. Aplasia cutis congenita following in utero methimazole exposure. Baid SK, Merke DP. J Pediatr Endocrinol Metab; 2007 May 02; 20(5):585-6. PubMed ID: 17642418 [No Abstract] [Full Text] [Related]
3. The association of aplasia cutis congenita with therapy of maternal thyroid disease. Kalb RE, Grossman ME. Pediatr Dermatol; 1986 Sep 02; 3(4):327-30. PubMed ID: 3774652 [Abstract] [Full Text] [Related]
4. Aplasia cutis congenita and other anomalies associated with methimazole exposure during pregnancy. Rodríguez-García C, González-Hernández S, Hernández-Martín A, Pérez-Robayna N, Sánchez R, Torrelo A. Pediatr Dermatol; 2011 Sep 02; 28(6):743-745. PubMed ID: 21995270 [Abstract] [Full Text] [Related]
6. Aplasia cutis congenita due to methimazol exposure within the first trimester of pregnancy: case report. Akar M, Dilli D, Sandal G, Erdeve Ö, Dilmen U. J Perinat Med; 2011 Nov 02; 39(6):743-4. PubMed ID: 21809898 [No Abstract] [Full Text] [Related]
7. Aplasia cutis congenita after methimazole exposure in utero. Karg E, Bereg E, Gaspar L, Katona M, Turi S. Pediatr Dermatol; 2004 Nov 02; 21(4):491-4. PubMed ID: 15283799 [Abstract] [Full Text] [Related]
8. [Aplasia cutis as a teratogenic effect of methimazole]. Díez-Delgado Rubio J, Belmonte Martín MJ, Calvo Bonachera MD, López Candel E. An Esp Pediatr; 1999 Sep 02; 51(3):290-2. PubMed ID: 10575754 [No Abstract] [Full Text] [Related]
11. Aplasia cutis congenita and skull defects after exposure to methimazole in utero. Nakamura S, Nishikawa T, Isaji M, Ishimori M, Shimizu N, Iwamura M, Nishikawa Y, Kubo M, Totani R. Intern Med; 2005 Nov 02; 44(11):1202-3. PubMed ID: 16357464 [No Abstract] [Full Text] [Related]
12. [Choanal atresia associated with the use of tapazol during pregnancy]. Fagundes TA, Reis JS, Rosário PW, Carvalho PA, Purisch S. Arq Bras Endocrinol Metabol; 2007 Dec 02; 51(9):1551-2. PubMed ID: 18209901 [No Abstract] [Full Text] [Related]
13. Aplasia cutis congenita after exposure to methimazole: a causal relationship? Vogt T, Stolz W, Landthaler M. Br J Dermatol; 1995 Dec 02; 133(6):994-6. PubMed ID: 8547058 [Abstract] [Full Text] [Related]
14. Digital hypoplasia and anticonvulsants during gestation: a teratogenic syndrome? Barr M, Poznanski AK, Schmickel RD. J Pediatr; 1974 Feb 02; 84(2):254-6. PubMed ID: 4204190 [No Abstract] [Full Text] [Related]
15. Choanal atresia and athelia: methimazole teratogenicity or a new syndrome? Greenberg F. Am J Med Genet; 1987 Dec 02; 28(4):931-4. PubMed ID: 3688031 [Abstract] [Full Text] [Related]
16. Choanal atresia and hypothelia following methimazole exposure in utero: a second report. Wilson LC, Kerr BA, Wilkinson R, Fossard C, Donnai D. Am J Med Genet; 1998 Jan 13; 75(2):220-2. PubMed ID: 9450891 [Abstract] [Full Text] [Related]
17. Malformations following methimazole exposure in utero: an open issue. Ferraris S, Valenzise M, Lerone M, Divizia MT, Rosaia L, Blaid D, Nemelka O, Ferrero GB, Silengo M. Birth Defects Res A Clin Mol Teratol; 2003 Dec 13; 67(12):989-92. PubMed ID: 14745920 [Abstract] [Full Text] [Related]
18. Methimazole embryopathy: delineation of the phenotype. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. Am J Med Genet; 1999 Mar 05; 83(1):43-6. PubMed ID: 10076883 [Abstract] [Full Text] [Related]
19. [Hydrotic (minor) form of ectodermal dysplasia]. Dethlefs B, Tronnier H. Hautarzt; 1972 Dec 05; 23(12):541-4. PubMed ID: 4649414 [No Abstract] [Full Text] [Related]
20. Aplasia cutis congenita after methimazole exposure in utero successfully treated with basic fibroblast growth factor. Abe M, Syuto T, Yokoyama Y, Ishikawa O. Int J Dermatol; 2010 Mar 05; 49(3):334-5. PubMed ID: 20465676 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]